Health IT News
Top stories summarized by our editors
7/19/2018

Health CIOs should consider using blockchain because the technology is likely to have a major effect on industries, businesses and society, according to a Gartner advisory. Meanwhile, the IDC issued a report recommending CIOs analyze the advantages and disadvantages of blockchain interoperability and urging hospitals to pursue blockchain interoperability and task coordination with patients and providers.

Full Story:
Healthcare IT News
7/18/2018

Cybersecurity incidents in the first quarter of the year were up 32% from the same period last year, a Positive Technologies report states. The report also states that malware attacks were up 75% from last year, while data theft rose 13%.

Full Story:
TechRepublic
More Summaries:
Positive Technologies
7/18/2018

An Australian study published in the Annals of Family Medicine showed that many mobile health apps that referenced mental health symptoms or diagnoses could be doing more harm than good. Researchers reviewed 61 popular mHealth apps and found that they "tended to encourage frequent use and promoted personal responsibility for improvement," with users "unlikely to get any significant benefits" and possibly facing "large time burdens and potential loss of privacy," lead study author Lisa Parker said.

Full Story:
mHealth Intelligence
More Summaries:
Lisa Parker
7/18/2018

A Frost & Sullivan study found that patient data privacy and medical device security are among the top areas for health care investments intended to reduce adverse patient safety events. The cost of adverse safety events is expected to surpass $380 billion for US and Western European health systems by 2022.

Full Story:
Health IT Security
7/18/2018

Cerner had the top hospital EHR market share at 23.73% as of June, followed by Epic at 22.14% and Meditech at 20.75%, according to data from the ONC. McKesson and MedHost, respectively, rounded out the top five.

More Summaries:
ONC, Cerner, Meditech, McKesson, MEDHOST
7/18/2018

A Frost & Sullivan report showed that the global medical device connectivity market, which generated $232.5 million last year, will likely rise into the billions by 2022, partly driven by the widespread adoption of EHR systems in hospitals. "For hospitals without EMR solutions, cloud-based device connectivity and digital dashboards for device data visualization will be an alternative," said Dinesh Kumar, a transformational health industry analyst at Frost & Sullivan.

More Summaries:
Frost & Sullivan, Sullivan
7/18/2018

Researchers evaluated free-text clinical notes from almost 18,000 senior patients and found that using a natural language processing algorithm to analyze unstructured EHR data may help identify more geriatric syndrome cases. The findings, published in the Journal of the American Geriatrics Society, showed that 6.7% of patients who exhibited symptoms of dementia were identified via the NLP algorithm, which was 1.5 times higher than previous estimates using only structured claims data.

7/18/2018

LDL cholesterol levels declined by 30% to 60% and PCSK9 levels dropped by 45% to 84% in rhesus macaques that had undergone genome editing to inactivate the PCSK9 protein in their livers, researchers reported in Nature Biotechnology. Scientists engineered a meganuclease to recognize and inactivate the PCSK9 gene and delivered the enzyme via an adeno-associated virus, validating an approach they hope to test in humans.

7/18/2018

A nanoparticle gel "backpack" bearing the cytokine IL-15 and attached to engineered chimeric antigen receptor T-cells eliminated signs of melanoma and glioblastoma in 60% of mice that received injections. The backpack activated more T-cells than free IL-15, and the mice tolerated high doses without adverse effects, the researchers reported in Nature Biotechnology.

Full Story:
Immuno-Oncology News
7/18/2018

The FDA approved a treatment for smallpox that was shown to be effective in monkeys and rabbits infected with a similar virus, and the US government has stockpiled 2 million units of the drug in case of a bioweapon attack. The drug may also be developed for use against monkeypox and other infectious diseases.